Now playing Next Europe News EU Policy. 8 MEPs who could dominate economic and finance policy The EU’s 720 lawmakers will spend the next five years pondering issues including a digital euro and capital markets reform – but which MEPs will likely stand out? 15/05/2024
Now playing Next Business 'Choose France' summit attracts record amount from foreign investment President Macron says funding from business giants such as Microsoft, Amazon, and Pfizer will benefit French citizens across the country. 13/05/2024
Now playing Next Business AstraZeneca stock up as it pulls Covid-19 vaccine from European market The pharma giant AstraZeneca has requested that the European authorisation for its Covid-19 vaccine be pulled, according to the EU medicines regulator. 09/05/2024
Now playing Next Europe News Six weirdest parties you can vote for in European elections Lots of political parties are bending over backwards to win your vote in June; others, not so much. 09/05/2024
Now playing Next Health news AstraZeneca asks for European approval of COVID jab to be pulled AstraZeneca was one of the first pharma laboratories to launch a COVID vaccine on the market at the end of 2020, a year after the virus appeared. 08/05/2024
Now playing Next Europe News Three key moments from the first debate with lead EU candidates The lead candidates in the European elections faced off against each other in the first debate of the race, haggling over the Green Deal, the Israel-Hamas war, irregular migration, artificial intelligence and TikTok, among others. 29/04/2024
Now playing Next Health news EU Policy. Commission approves superbug-busting antibiotic The European Commission today (22 April) authorised a new antibiotic designed to counter anti-bacterial resistance, one of the biggest health threats the EU is currently facing. 22/04/2024
Now playing Next Health news What is Pregabalin and why is it causing concern in the UK? The anti-anxiety drug has been linked to fatalities in the UK, leading people taking the drug to come forward about their debilitating side effects. 07/03/2024
Now playing Next Health news Officials look into rare disorder in older adults who got RSV vaccine Officials are investigating a rare nervous system disorder in older adults who received the RSV vaccine. 01/03/2024
Now playing Next Health news Why is €2 billion worth of COVID drug Paxlovid going to waste? European countries rushed to buy the antiviral drug in January 2022, but now it’s going to waste. Why? 24/02/2024
Now playing Next Markets Novo Nordisk crossroads: Can the pharma giant address the supply woes? Novo Nordisk faces a pivotal moment as it grapples with supply issues amid soaring demand for its weight-loss drugs. Despite impressive financial gains and market dominance, the Danish pharma giant must navigate a critical decision. 10/02/2024
Now playing Next Health news COVID vaccine may have short-term impact on menstrual cycles - study A French study found an increased but short-term risk of changes to women's menstrual cycles after they received the COVID-19 mRNA vaccine. 01/02/2024
Now playing Next Culture news What is Biden’s ‘Taylor Swift Plan’ – and why is MAGA on the warpath? President Joe Biden is reportedly seeking TayTay’s endorsement once more in order to swing this year’s US presidential election – something which has led to some outrageous conspiracy theories. Here’s the breakdown. 31/01/2024
Now playing Next Business Have healthcare stocks been under the weather in 2023? Euronews Business looks at how major healthcare stocks such as Pfizer and Moderna performed this year 29/12/2023
Now playing Next Business Why has Italy abandoned the New Silk Road project with China? Italy exits the New Silk Road: Euronews Business explores what this agreement encompasses and which countries are still involved. 07/12/2023
Now playing Next Business UK welcomes almost £30bn of investment ahead of Global Summit Thousands of jobs will be created as investors show a “vote of confidence” in the UK economy, says Prime Minister Rishi Sunak. 27/11/2023
Now playing Next Business Denmark's Novo Nordisk invests €2.1 billion in France Danish pharmaceutical giant Novo Nordisk has announced major investment in a French production site to expand the capacity and manufacturing of its blockbuster anti-obesity drug. 24/11/2023